OBI Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	395.32	759.33	1,732	899.28	4,741	2,512
Short-Term Investments	407	427	1,399	1,883	30.71	140
Trading Asset Securities	-	-	0.09	0.23	0.75	1.77
Cash & Short-Term Investments	802.32	1,186	3,131	2,782	4,773	2,654
Cash Growth	-67.29%	-62.11%	12.53%	-41.70%	79.83%	-28.69%
Accounts Receivable	3.06	12.71	4.2	6.48	2.04	3.47
Other Receivables	266.42	307.4	246.34	225.86	26.24	19.8
Receivables	269.48	320.11	250.54	232.34	28.27	23.27
Inventory	19.72	18.43	27.73	25.93	21.97	9.56
Prepaid Expenses	42.7	55.22	30.68	26.38	211.26	167.35
Other Current Assets	-	-	-	100.34	-	-
Total Current Assets	1,134	1,580	3,440	3,167	5,034	2,854
Property, Plant & Equipment	927.34	994.29	1,165	1,249	1,176	1,149
Long-Term Investments	704.32	747.34	946.95	1,070	8.73	9.11
Goodwill	-	-	-	-	61.15	61.15
Other Intangible Assets	43.21	46.86	62.84	73.18	321.29	337.14
Other Long-Term Assets	53.16	52.69	39.03	51.64	32.9	76.21
Total Assets	2,862	3,421	5,654	5,611	6,634	4,487
Accounts Payable	2.73	0.99	3.44	0.77	1.14	0.53
Accrued Expenses	106.7	92.18	251.9	65.76	112.49	177.82
Short-Term Debt	53.87	50.35	0.41	4.31	15.71	-
Current Portion of Long-Term Debt	72.16	71.87	34.09	7	7	7
Current Portion of Leases	49.41	54.02	55.12	49.86	40.35	52.07
Current Income Taxes Payable	3.7	2.46	10.39	1.58	0.56	0.34
Current Unearned Revenue	8.82	2.29	7.78	6.29	3.16	-
Other Current Liabilities	32.75	76.4	49.24	30.28	40.73	89.47
Total Current Liabilities	330.14	350.56	412.37	165.84	221.14	327.22
Long-Term Debt	11.3	29.46	48.22	60.06	67.07	28
Long-Term Leases	275.04	309.98	366.79	425.89	163.03	205.96
Long-Term Deferred Tax Liabilities	-	-	-	-	46.33	54.76
Other Long-Term Liabilities	6.17	6.14	6.01	5.89	0	-
Total Liabilities	622.65	696.13	833.39	657.67	497.57	615.95
Common Stock	1,316	1,316	2,632	2,294	2,294	1,993
Additional Paid-In Capital	9,218	-	-	7,128	6,933	3,702
Retained Earnings	-9,057	-8,616	-7,879	-5,569	-4,523	-2,909
Treasury Stock	-	-	-26.53	-26.53	-45.99	-45.99
Comprehensive Income & Other	-11.5	9,189	9,089	-19.87	-26.32	-24.53
Total Common Equity	1,466	1,889	3,815	3,807	4,632	2,716
Minority Interest	774.05	836.58	1,006	1,147	1,504	1,155
Shareholders' Equity	2,240	2,725	4,820	4,953	6,136	3,871
Total Liabilities & Equity	2,862	3,421	5,654	5,611	6,634	4,487
Total Debt	461.79	515.68	504.63	547.11	293.15	293.03
Net Cash (Debt)	340.53	670.65	2,626	2,235	4,479	2,361
Net Cash Growth	-82.49%	-74.46%	17.49%	-50.10%	89.73%	-32.08%
Net Cash Per Share	2.59	5.10	22.48	19.52	40.33	23.73
Filing Date Shares Outstanding	131.58	131.58	131.48	114.62	114.55	99.47
Total Common Shares Outstanding	131.58	131.58	131.48	114.62	114.55	99.47
Working Capital	804.08	1,230	3,027	3,001	4,813	2,527
Book Value Per Share	11.14	14.35	29.01	33.21	40.44	27.30
Tangible Book Value	1,422	1,842	3,752	3,734	4,250	2,318
Tangible Book Value Per Share	10.81	14.00	28.53	32.57	37.10	23.30
Land	-	-	-	-	87.51	87.51
Buildings	344.49	344.49	344.49	343.2	370.02	329.28
Machinery	1,064	1,061	1,080	1,022	1,054	671.26
Construction In Progress	0.37	1.65	10.07	66.46	35.74	368.45
Leasehold Improvements	266.36	265.97	276.85	181.24	184.06	65.85